E2 ModeratePreliminaryPEM not requiredCross-SectionalPeer-reviewedReviewed
Glucocorticoid receptor mediated negative feedback in chronic fatigue syndrome using the low dose (0.5 mg) dexamethasone suppression test.
Papadopoulos, Andrew, Ebrecht, Marcel, Roberts, Amanda D L et al. · Journal of affective disorders · 2009 · DOI
Quick Summary
This study looked at how the body's stress hormone system works in ME/CFS patients. Researchers gave a small dose of a synthetic hormone called dexamethasone to 18 ME/CFS patients and 20 healthy people, then measured how much their natural stress hormone (cortisol) decreased in response. Interestingly, ME/CFS patients who also had depression showed a larger drop in cortisol than healthy controls, suggesting their feedback system may be working overtime.
Why It Matters
Understanding the cortisol feedback system in ME/CFS may help explain why this disease causes such profound fatigue and why some patients have comorbid depression. This research provides insight into whether abnormal stress hormone regulation contributes to ME/CFS symptoms and could eventually lead to better-targeted treatments.
Observed Findings
- CFS patients in this sample had elevated basal cortisol output compared to controls, an atypical finding.
- Overall cortisol suppression after dexamethasone was similar in CFS patients (80.4%) and controls (76.2%).
- The CFS subgroup with comorbid depression (n=9) showed significantly greater cortisol suppression (89.0%) compared to controls (p<0.05).
- Cortisol was measured at four timepoints (0800h, 1200h, 1600h, 2000h) before and after dexamethasone administration.
Inferred Conclusions
- Enhanced glucocorticoid-mediated negative feedback may be present in CFS patients with comorbid depression, but not necessarily in all CFS patients.
- The relationship between cortisol feedback and depression status in CFS warrants further investigation.
- The atypical elevation of basal cortisol in this CFS sample suggests heterogeneity in cortisol abnormalities within the ME/CFS population.
Remaining Questions
- Does enhanced cortisol feedback occur in ME/CFS patients without depression, or is it specific to those with comorbid mood disorders?
- Why did this CFS sample show elevated basal cortisol when most literature reports hypocortisolism, and does this represent a distinct biological subtype?
- How does mineralocorticoid feedback contribute to the overall HPA axis dysfunction in ME/CFS, and is it also altered in patients with comorbid depression?
What This Study Does Not Prove
This study does not prove that enhanced cortisol feedback causes ME/CFS or that it is present in all ME/CFS patients—findings were limited to the comorbid depression subgroup. The elevated basal cortisol in this sample differs from most published research, so results may not generalize to the broader ME/CFS population. The study also could not fully assess the complete feedback system, as it only measured glucocorticoid feedback and not mineralocorticoid feedback.
Tags
Symptom:Fatigue
Biomarker:Blood Biomarker
Method Flag:Weak Case DefinitionSmall SampleExploratory Only
Metadata
- DOI
- 10.1016/j.jad.2008.05.001
- PMID
- 18573538
- Review status
- Editor reviewed
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 12 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.